The alliance is calling for all third-party medical equipment servicers to be required to register with – and abide by regulations from – the FDA.
Worries over equipment maintenance provided by third-party servicers has been a long-standing concern for radiology leaders. In its latest push for greater safety, the Medical Imaging & Technology Alliance (MITA) released a white paper this week, calling for third-party servicers to register with the U.S. Food & Drug Administration (FDA).
Related Content: MITA Calls for FDA Registration for Third-Party Medical Device Servicers
Currently, third-party groups are not subject to the same requirements and regulations that govern original equipment manufacturers and healthcare facilities. Instead, they abide by voluntary standards. This situation has resulted in multiple scenarios that put both patients and providers at significant risk, including instances of equipment that have been repaired with tape or twist ties, as well as improper ventilation.
Related Content: Hey FDA, There’s No Need to Add to Cancer Patients' Scanxiety
Diagnostic Imaging spoke this week with Peter Weems, MITA senior director of strategic operations and policy, about the pervasiveness of this issue and the threats it presents. He also shared details on the ongoing efforts to require FDA registration for these services and what individual radiologists and rad techs can do to participate, directing providers and other interested parties to Protect Safe Servicing, a website that can provide more information about the risks of third-party servicing, how to address the problem, and case studies of unsafe incidents.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.